4,4'-(1,4-PIPERAZINEDIYLBIS(METHYLENE))BIS(N-(4-METHYL-3-((4-(3-PYRIDINYL)-2-PYRIMIDINYL)AMINO)PHENYL)BENZAMIDE)
UNII 3UX2VT8LAN

Substance Identification & Data

This profile provides standardized clinical and technical data for 4,4'-(1,4-piperazinediylbis(methylene))bis(n-(4-methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)phenyl)benzamide), uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3UX2VT8LAN.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1365802-18-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

3UX2VT8LAN

CAS Registry Number

1365802-18-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

4,4'-(1,4-PIPERAZINEDIYLBIS(METHYLENE))BIS(N-(4-METHYL-3-((4-(3-PYRIDINYL)-2-PYRIMIDINYL)AMINO)PHENYL)BENZAMIDE)

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C52H48N12O2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

DZHKYOWYCVBDPW-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

71315751

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

N(c1nc(ccn1)-c2cccnc2)c3cc(NC(=O)c4ccc(CN5CCN(Cc6ccc(C(Nc7cc(Nc8nc(ccn8)-c9cccnc9)c(C)cc7)=O)cc6)CC5)cc4)ccc3C

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 4,4'-(1,4-piperazinediylbis(methylene))bis(n-(4-methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)phenyl)benzamide). Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.